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Abstract
Silathiazolidine and metalladithioacetals (M Si, Ge) have been prepared by the
interaction of dialkyldichloro- or bis(diethylamino)dialkylsilanes and -germanes with 3-[N-(2-
thioethyl)]amino-propanamide (WR-2529) and [1-thioethyl-2-(1-naphtylmethyl)]-2-
imidazoline. The study of these compounds in the field of chemical radioprotection has
shown a notable decrease in the toxicity and a rather large increase in the radioprotective
activity of these new derivatives in comparison with the starting organic compounds.
Introduction
Current interest in the radioprotective activity of several classes of organosilicon and
organogermanium derivatives is attested by a growing number of reported syntheses in this
area [1-10]. This report concerns the synthesis, toxicity and study of the biological activity of
some new silathiazolidine, sila- and germadithioacetals (see scheme).
Materials and methods
All manipulations were carried out under dry nitrogen. Solvents were freshly distilled
from sodium/benzophenone before use. IR spectra were recorded on a Perkin-Elmer 1600FT-
IR spectrophotometer. 1H and 13C NMR spectra were recorded on Bruker’s AC 80 (80.13 MHz)
and AC 200 (50.32 MHz) spectrometers; the multiplicity of the 13C NMR signals was
determined by the APT technique and quoted (-) for CH3 and CH, (+) for CH2 and (Cquat) for
quaternary carbon atoms. Mass spectra under electron impact (El) conditions at 70 and 30
eV were recorded on a Hewlett-Packard 5989A spectrometer. Elemental analyses (C, H, N)
were performed at the Laboratoire de Microanalyse de I’Ecole Nationale Superieure de
Chimie de Toulouse.
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Silathiazolidine 1
This compound was prepared by two methods: A and B
Method A
Di-n-hexyldichlorosilane (3.91 g, 14.51 mmol) in 50 ml of THF was added dropwise to a
stirred mixture of 3-[N-(2-thioethyl)]aminopropanamide [11] (2.15 g, 14.51 mmol) and freshly
distilled triethylamine (3.23 g, 31.92 mmol) in 70 ml of THF. The reaction mixture was
refluxed for 2 h with stirring. After cooling, the mixture was filtered under nitrogen to remove
the precipitate Et3N.HCI. Removal of volatiles (under reduced pressure) from the filtrate, the
residue was extracted by 40 ml of dry pentane. Filtration and concentration, afforded 1 (3.88
g, 78 %).
Method B
To a stirred mixture of 3-[N-(2-thioethyl)]aminopropanamide [11] (1.60 g, 10.80 retool)
in 50 ml of THF was added dropwise, a solution of bis(diethylamino)di-n-hexylsilane (3.70 g,
10.80 retool) in 50 ml of THF. The mixture was refluxed under nitrogen for 3 h. The volatile
material was removed in vacuo to afford the compound 1 (3.57 g, 96 %).
Sila- and germadithioacetals 2-7
These compouds were also synthesized by two methods: C and D
Method C
Diisoamyldichlorosilane (1.82 g, 7.55 retool) in 30 ml of THF was added dropwise to a
stirred mixture of 3-[N-(2-thioethyl)]aminopropanamide (2.24 g, 15.11 retool) and freshly
distilled triethylamine (1.68 g, 16.62 mmol) in 50 ml of THF. After refluxing for 3 h, the
resulting mixture was cooled down to room temperature, filtered and evaporated under
vacuum. The residue was extracted in 30 ml of dry pentane. Filtration, followed by removal
of the solvent under vacuum gave 2 (1.99 g, 57 %).
Method D
Bis(diethylamino)di-n-hexylsilane (2.00 g, 5.84 mmol) in 40 ml of THF was added
dropwise with stirring to a suspension of HSCH2CH2NHCH2CH2C(O)NH2 (1.73 g, 11.67 mmol) in
70 ml of THF. The mixture was refluxed under nitrogen for 3 h. After cooling down to room
temperature, the volatiles were removed under vacuum to afford 3 (2.02 g, 70 %).
Compounds 4-7 were prepared analogously from the appropriate
dialkyldichlorometallane or bis(diethylamino)dialkylmetallane and 3-[N-(2-
thioethyl)]aminopropanamide or [1-thioethyl-2-(1-naphtylmethyl)]-2-imidazoline.
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[1-Thioethyl-2-(1-naphtylmethyl)]-2-imidazoline 8
A solution of 2-(1-naphtylmethyl)-2-imidazoline# (5.29 g, 25.16 mmol) in 60 ml of dry
toluene was mixed with a solution of ethylene sulfide (1.59 g, 26.45 mmol) (Aldrich-
Chemical) in 40 ml of dry toluene (sealed tube, argon flushed). The reaction mixture was
then heated (110C oven) for 15 h. After cooling 100 ml of cold diethyl ether was added with
stirring to reaction mixture, and filtration to remove small amount of polyethylene sulfide.
The solvent was removed under reduced pressure to give a yellow pasty product 8 (4.78 g, 74
%).
#To a solution of 2-(1-naphthylmethyl)-2-imidazoline hydrochloride (Aldrich-Chemical)
(30g, 121.58 mmol) in 30 ml of water was added with stirring a solution of NaOH 14 % (34.73
g). After extraction with toluene (500 ml), the organic layer dried on Na2SO4. Removal of
solvent in vacuo and crystallization from THF/diethyl ether (1/9, 400 ml) gave 2-(1-
naphtylmethyl)-2-imidazoline in form of white crystals (21.31 g, 87 %).
Physicochemical data of derivatives 1-8 are reported in Table
Compound
Table II- Radioprotective activity of 1
LDso: mg.kg Injected Irradiation
(mmol)
> 1500
(4.35)
> 800
(1.72)
> 1500
(3.04)
~100
(0.14)
~100
(0..13)
~8O
(o.)
-150
(0.19)
(0.13)
dose
m.k
1
1000
1000
600
750
5O
5O
12.5
5O
5O
5O
12.5
5O
5O
5O
12.5
5O
5O
5O
75
75
18.75
75
17.5
4.38
Gy (t, min)
a
8 (15)
8(90)
7.5 (15)
8 (15)
7.75 (15)
7.75 (90)
7.75 (15)
9.75 {15)
7.75 (15)
7.75 (90)
7.75 (15)
7.75 (15)
7.75 (90)
7.75 (180)
7.75 (15)
9.75 (15)
9.75 (90)
11.75 (15)
7.75 (15)
7.75 (90)
7.75 (15)
9.75 (15)
8 (15)
8 (15)
-8 compounds
Survival rate
%
DRF
D
70
30
20
60
100
8O
60
10
100
100
5O
00
100
90
80
70
0
30
90
100
70
10
8O
47
1.2
1.4
1.5
1.25
1.4
1.1
a: = time between administration of compound and ’irradiation.
b: dose reduction factor = (LDo(3o days)treated/LDo(3o days) untreated).
Pharmacology: evaluation of radioprotection
Male CD1 mice (Charles River, France), 25 g body weight, were used. Compounds were
injected intraperitoneally 15, 90 or 180 min before irradiation. The irradiation dose was
LDloo/30 days for untreated mice (7.5, 7.75 or 8 Gy, according to the irradiation date) or a 2
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Gy greater dose. The injected dose of compound was equal to, three-quater, two-third, one-
half or one eighth of the LDo value which had been determined previously. The
radioprotective effect was evaluated by the Dose Reduction Factor (DRF), which is the ratio
between the LDo/30 days of treated mice and that of control mice (between 6.5 and 6.75
Gy, according to the date).
Irradiation was applied using a cobalt-60 source at the dose rate of 0.3-0.4 Gy.min
1
according to the date. During irradiation, animals were placed in a Plexiglass box with 30
cells in a homogeneous field, 28.5 x 28.5 cm in area. Dosimetry was checked with an
ionisation chamber dosimeter. The different LDso values were determined by probit analysis.
Results and discussion
Silathiazolidine
Silathiazolidine has been prepared according to two methods of heterocyclisation
already described in the litterature [1, 12, 13].
Method A
The action of di-n-hexyldichlorosilane, in stoichiometric amounts, on 3-[N-(2-
thioethyl)]aminopropanamide in refluxing anhydrous THF in the presence of freshly distilled
triethylamine gave by a cyclisation reaction, with elimination of hydrochloric acid from Si-CI
and NH groups [13], the corresponding product, Scheme 1:
(n-C6Hla)2SiCI2 + HSCH2CH2NHCH2CH2 NH2
+ 2Et3N
S
6H2CH2NH2
Scheme 1
Method B
Treatment of bis(diethylamino)-di-n-hexylsilane, in stoichiometric amounts, with 3-[N-
(2-thioethyl)]aminopropanarnide in anhydrous THF resulted in the cleavage of Si-N bonds by
the N-H (a transamination reaction) and S-H groups [1,13,15] forming the corresponding
silathiazolidine, Scheme 2:
(n-CI13)2Si(NEt2)2 + HSCH2CH2NHCH2CH2, NH2
(n-C6H13)2Si
+ 2 Et2NH
(H2CH2IH2
Scheme 2
Sila- and germadithioacetals
These compounds were also synthesized by two methods, C and D.
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Method C
The reaction of dialkyldichlorosilanes and -germanes with two equivalents of 3-[N-(2-
thio-ethyl)]aminopropanamide or [1-thioethyl-2-(1-naphtylmethyl)]-2-imidazoline in the
presence of tri-ethylamine in refluxing anhydrous THF leads to the acyclic derivatives,
Scheme 3:
+ 2Et3N R2MCI2 + 2R’CH2CH2SH R2M(SCH2CH2R’)2 + 2Et3N.HCI
Scheme 3
Method D
The action of two equivalents of 3-[N-(2-thioethyl)]aminopropanamide or [1-thioethyl-2-
(1-naphtylmethyl)]-2-imidazoline with bis(diethylamino)dialkylsilanes and -germanes in
anhydrous THF, a cleavage reaction of M-N bonds by the N-H (a transamination reaction)
and S-H groups [1, 13, 15] leads to the formation of the desired products, Scheme 4
R2M(NEt2)2 + 2R’CH2CH2SH R2M(SCH2CH2R’)2 + 2 Et2NH
Scheme 4
Synthesis of [1 -thioethyl-2-(1-naphtylmethyl)]-2-imidazoline
This compound was obtained by the reaction of 2-(1-naphtylmethyl)-2-imidazoline with
ethy-lene sulfide in a sealed tube at 110C in anhydrous toluene (i.e. by a cleavage of the C-
S bond by the N-H group) [16], Scheme 5:
toluene
110C
Scheme 5
CH2SH
Conclusions
The experimental evaluation of toxicity and radioprotective activity of
metalladithioacetals and silathiazolidine 1-7 in the mice is presented in Table I1.
Compounds 1 and 3 showed a lower toxicity (LDo > 1500 mg.kg) compared with the
starting organic derivative HSCH2CH2NHCH2CH2C(O)NH2 (WR-2529) LDo = 700 mg.kg [10].
With the other sila- and germadithioacetals, derivatives 4-7, we have observed a low
decrease of the toxicity but a good radioprotective activity by intraperitoneal administration
in mice. For example:
derivative 4: at LDo/2 50 mg.kg
1 this product protects 100 % and 80 % of mice
when 4 was injected 15 and 90 minutes before irradiation.
derivative 5: at LDo/2 50 mg.kg this product protects 100 % of mice when 5 was
injected 15 and 90 minutes before irradiation. In the example shown, 50 % survival was also
observed at LDo/8.
Concerning the derivatives 6 and 7 we have noted a low toxicity and a notable
increase of radioprotective activity:
derivative 6: at LDo/1.6 50 mg.kg this product protects 100 % of mice when 6
was injected 15 and 90 minutes before irradiation, 90 % survival when 6 was injected 180
minutes before irradiation. At LD0/6.4 there was still 80 % survival and at LDso/1.6, 70 and 30
% survival at dose of 9.75 and 11.75 Gy.
derivative 7: at LDo/2 75 mg.kg this product protects 90 and 100 % of mice
when 7 was injected 15 and 90 minutes before irradiation. At LDo/8, 70 % survival when 7
was injected 15 minutes before irradiation.
Chemical radioprotective study of silathiazolidine and metalladithioacetals showed a
low toxicity and more potent protection than HSCHCHNHCHCHC(O)NH (WR-2529) or
derivative 8.
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The results reported in this paper confirm the positive contribution of silicon and
germanium in this field in agreement with previous works [1-10] and the interesting biological
activity of organosilicon and organogermanium compounds in different fields [17-25].
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